Frédéric Calon

Professeur titulaire

Laval University

Canada

Research Interests

Explore related searches

Professors in Canada

Contact this professor

ORCID

Google Scholar

About

Frédéric Calon is a Professeur titulaire at Université Laval in Canada. His research focuses on neurodegenerative diseases such as Alzheimer's and Parkinson's, with recent articles examining the effects of natural health products, metabolic factors, and diet on these conditions. He also investigates the role of various biomarkers and neurorestorative strategies in the context of age-related neurological health.

Frédéric Calon

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.

Aging, sex, metabolic and life experience factors: Contributions to neuro-inflammaging in Alzheimer’s disease research

Natural Health Products for Symptomatic Relief of Parkinson's Disease: Prevalence, Interest, and Awareness.

Cerebrospinal fluid soluble insulin receptor levels in Alzheimer's disease.

Lower GLUT1 and unchanged MCT1 in Alzheimer's disease cerebrovasculature.

Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease.

Pre-operative levels of angiopoietin protein-like 3 (ANGPTL3) in women diagnosed with high-grade serous carcinoma of the ovary.

High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?

Postsynaptic protein Shank3a deficiency synergizes with Alzheimer's disease neuropathology to impair cognitive performance in the 3xTg-AD murine model.

Cerebrovascular insulin receptors are defective in Alzheimer’s disease

Direct and Indirect Effects of Filamin A on Tau Pathology in Neuronal Cells

Investigating the plasma-liver-brain axis of omega-3 fatty acid metabolism in mouse knock-in for the human apolipoprotein E epsilon 4 allele

Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

How nutrients and natural products act on the brain: Beyond pharmacology.

Combining NGN2 programming and dopaminergic patterning for a rapid and efficient generation of hiPSC-derived midbrain neurons.

Inhibition of PLK2 activity affects APP and tau pathology and improves synaptic content in a sex-dependent manner in a 3xTg mouse model of Alzheimer's disease.

Evidence of Filamin A loss of solubility at the prodromal stage of neuropathologically-defined Alzheimer's disease.

Risk of Neutropenia in Adults Treated with Piperacillin-Tazobactam or Cefazolin: A Retrospective Cohort Study.

Sauna-like conditions or menthol treatment reduce tau phosphorylation through mild hyperthermia.

Circulating levels of PCSK9, ANGPTL3 and Lp(a) in stage III breast cancers

Collaborators (5)

Maud Gratuze

Luc Bergeron

Christoph Rummel

Razan Sheta

Melanie Plourde

How do I reach out?

Meet Kite AI